(lp0
S"DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings ... PR Newswire  - Feb 24, 2017 CUPERTINO, Calif., Feb. 24, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's  fourth quarter 2016 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet ...To Buy Or Sell Durect Corporation  On Latest Analyst Consensus - Fiscal Standard"
p1
aS'DURECT Corporation Announces Third Quarter 2016 Financial Results and Update ... PR Newswire  - Oct 31, 2016 CUPERTINO, Calif., Oct. 31, 2016 /PRNewswire/ -- DURECT Corporation  announced today financial results for the third quarter of 2016.'
p2
aS"Here's Why DURECT Corporation Is Tanking Today Motley Fool - Sep 26, 2016 Investors in DURECT Corporation , a specialty pharmaceutical company that develops anti-abuse drug technology, are having a rough start to the trading week.Company Update : Here's Why DURECT Corporation Shares Fall 30% - Smarter AnalystDurect Corp.  Stock Tumbles on FDA Opioid Analgesic Drug Rejection - TheStreet.com"
p3
aS"DURECT Corporation Announces Update on DUR-928 Development Program PR Newswire  - Jan 30, 2017 30, 2017 /PRNewswire/ -- DURECT Corporation  today provided an update on the DUR-928 development program. DUR-928, our Epigenetic Regulator Program's lead product candidate, is an endogenous, small molecule, new chemical&nbsp;...DURECT says FDA wants more more drug-drug interaction data on lead candidate ... - Seeking Alpha"
p4
aS'DURECT Corporation Announces Fourth Quarter and Full Year 2016 Financial ... PR Newswire  - Mar 14, 2017 NOTE: POSIMIR, SABER, and ORADUR are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.'
p5
aS'Stock Volatility Risk Alert: DURECT Corporation Realized Volatility Hits A ... CML News - 9 hours ago Before we cover the full analysis we make a quick alert here that DURECT Corporation  has seen its stock price whip around at an escalated level.'
p6
aS"Durect Corp. DRRX  Wall Street Journal - Feb 11, 2011 P/E Ratio : The Price to Earnings  ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period ..."
p7
aS"DURECT Corporation  Settles Into New 52-Week Low on February 16 Session Equities.com - Feb 16, 2017 Shares of DURECT Corporation  sank into a new 52-week low yesterday, and could be a company to watch at the open. The company's stock fell to as low as $0.97 yesterday after opening at $0.99."
p8
aS'How To Trade Durect Heading Into Remoxy Decision Date Seeking Alpha - Aug 2, 2016 FDA decisions can make or break developmental-stage pharmaceutical companies. With millions of dollars invested in the development of a drug, an FDA decision represents the culmination of years of hard work and millions of dollars in investment.'
p9
aS'DURECT Announces Initiation of DUR-928 Dosing in Patients PR Newswire  - Jan 11, 2016 CUPERTINO, Calif., Jan. 11, 2016 /PRNewswire/ -- DURECT Corporation  today announced it has initiated a single-ascending-dose Phase 1b clinical trial with DUR-928 in patients with nonalcoholic steatohepatitis .'
p10
a.